Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma

被引：1
作者：
Takiar, Radhika [1 ]
Phillips, Tycel J. [1 ,2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI USA
[2] City Hope Natl Med Ctr, Dept Hematol, Div Hematol, 1500 East Duarte Rd, Duarte, CA 91010 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 12期
基金：
美国国家卫生研究院;
关键词：
CRIZOTINIB; FUSION;
D O I：
10.1182/bloodadvances.2022007537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2912 / 2916
页数：5
相关论文
共 20 条
  • [1] Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy
    Bossi, Elisa
    Aroldi, Andrea
    Brioschi, Filippo A.
    Steidl, Carolina
    Baretta, Silvia
    Renso, Rossella
    Verga, Luisa
    Fontana, Diletta
    Sharma, Geeta G.
    Mologni, Luca
    Mussolin, Lara
    Piazza, Rocco
    Gambacorti-Passerini, Carlo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : E319 - E321
  • [2] Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas
    Cerchietti, Leandro
    Damm-Welk, Christine
    Vater, Inga
    Klapper, Wolfram
    Harder, Lana
    Pott, Christiane
    Yang, Shao Ning
    Reiter, Alfred
    Siebert, Reiner
    Melnick, Ari
    Woessmann, Willi
    [J]. PLOS ONE, 2011, 6 (04):
  • [3] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
    Christensen, James G.
    Zou, Helen Y.
    Arango, Maria E.
    Li, Qiuhua
    Lee, Joseph H.
    McDonnell, Scott R.
    Yamazaki, Shinji
    Alton, Gordon R.
    Mroczkowski, Barbara
    Los, Gerrit
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3314 - 3322
  • [4] ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
    De Paepe, P
    Baens, M
    van Krieken, H
    Verhasselt, B
    Stul, M
    Simons, A
    Poppe, B
    Laureys, G
    Brons, P
    Vandenberghe, P
    Speleman, F
    Praet, M
    De Wolf-Peeters, C
    Marynen, P
    Wlodarska, I
    [J]. BLOOD, 2003, 102 (07) : 2638 - 2641
  • [5] A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation
    Delsol, G
    Lamant, L
    Mariame, B
    Pulford, K
    Dastugue, N
    Brousset, P
    RigalHuguet, F
    AlSaati, T
    Cerretti, DP
    Morris, SW
    Mason, DY
    [J]. BLOOD, 1997, 89 (05) : 1483 - 1490
  • [6] Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
    Gambacorti-Passerini, Carlo
    Orlov, Sergey
    Zhang, Li
    Braiteh, Fadi
    Huang, Huiqiang
    Esaki, Taito
    Horibe, Keizo
    Ahn, Jin-Seok
    Beck, Joseph T.
    Edenfield, William Jeffrey
    Shi, Yuankai
    Taylor, Matthew
    Tamura, Kenji
    Van Tine, Brian A.
    Wu, Shang-Ju
    Paolini, Jolanda
    Selaru, Paulina
    Kim, Tae Min
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 607 - 614
  • [7] ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements:: report of 6 cases
    Gascoyne, RD
    Lamant, L
    Martin-Subero, JI
    Lestou, VS
    Harris, NL
    Müller-Hermelink, HK
    Seymour, JF
    Campbell, LJ
    Horsman, DE
    Auvigne, I
    Espinos, E
    Siebert, R
    Delsol, G
    [J]. BLOOD, 2003, 102 (07) : 2568 - 2573
  • [8] Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia
    Giuriato, Sylvie
    Foisseau, Marianne
    Dejean, Emilie
    Felsher, Dean W.
    Al Saati, Talal
    Demur, Cecile
    Ragab, Ashraf
    Kruczynski, Anna
    Schiff, Claudine
    Delsol, Georges
    Meggetto, Fabienne
    [J]. BLOOD, 2010, 115 (20) : 4061 - 4070
  • [9] Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
    Heuckmann, Johannes M.
    Balke-Want, Hyatt
    Malchers, Florian
    Peifer, Martin
    Sos, Martin L.
    Koker, Mirjam
    Meder, Lydia
    Lovly, Christine M.
    Heukamp, Lukas C.
    Pao, William
    Kueppers, Ralf
    Thomas, Roman K.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4682 - 4690
  • [10] Anaplastic Lymphoma Kinase-Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis
    Laurent, Camille
    Do, Catherine
    Gascoyne, Randy D.
    Lamant, Laurence
    Ysebaert, Loic
    Laurent, Guy
    Delsol, Georges
    Brousset, Pierre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4211 - 4216
12